Magnus Financial Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Magnus Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29M	Sell	38,034 -50	-0.1%	-$1.67K	0.09%	139
2026 Q1	$1.15M	Buy	38,084 +210	+0.6%	+$6.76K	0.09%	139
2025 Q4	$1.18M	Buy	37,874 +8,235	+28%	+$203K	0.09%	151
2025 Q3	$599K	Buy	+29,639	New	+$521K	0.05%	228

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Magnus Financial Group's TEVA Position: Q2 2026 in Review

Magnus Financial Group reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 0.13% in Q2 2026, selling an estimated $1.67K and leaving 38,034 shares worth $1.29M. The position accounts for 0.09% of the portfolio, ranked #139.

Magnus Financial Group first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Magnus Financial Group held 38,034 shares of Teva Pharmaceutical Industries Limited worth $1.29M as of Q2 2026.
Magnus Financial Group sold 50 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $1.67K.
Teva Pharmaceutical Industries Limited made up 0.09% of Magnus Financial Group's portfolio in Q2 2026, its #139 holding.
Magnus Financial Group first reported a position in Teva Pharmaceutical Industries Limited in Q3 2025 and has held it in 4 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.